Molecular Diagnostics
News on lab-developed tests and emerging diagnostic technologies.
G42 Healthcare, Seegene to Offer Mobile Molecular Diagnostic Labs in Middle East, North Africa
Under the partnership, the firms will offer the Seegene Mobile Station, a laboratory-on-wheels facility for molecular diagnostic testing.
Berry Oncology, Alibaba Health Partner to Offer Early Cancer Screening, Health Services
As part of the deal, the companies will offer Berry Oncology's Lai Si Ning next-generation sequencing-based liver cancer screening test.
Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test
The Cobas test is the first molecular, point-of-care test to receive Emergency Use Authorization for asymptomatic people.
Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test
SARS-CoV-2 testing has become a major part of Co-Diagnostics' business, accounting for the lion's share of the company's revenues recently.
A new publication detailing ctDNA testing results has spurred a minimal residual disease biomarker-directed trial for Roche's atezolizumab in bladder cancer.